Glucose metabolism in cardiac hypertrophy and heart failure
Heart failure is one of the leading causes of death worldwide and has been singled out as
an emerging epidemic. 1, 2 With a 5-year survival rate of 50%, heart failure poses a …
an emerging epidemic. 1, 2 With a 5-year survival rate of 50%, heart failure poses a …
Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes
The network for cardiac fuel metabolism contains intricate sets of interacting pathways that
result in both ATP-producing and non–ATP-producing end points for each class of energy …
result in both ATP-producing and non–ATP-producing end points for each class of energy …
Myocardial fatty acid metabolism in health and disease
There is a constant high demand for energy to sustain the continuous contractile activity of
the heart, which is met primarily by the β-oxidation of long-chain fatty acids. The control of …
the heart, which is met primarily by the β-oxidation of long-chain fatty acids. The control of …
[HTML][HTML] Targeting fatty acid and carbohydrate oxidation—a novel therapeutic intervention in the ischemic and failing heart
Cardiac ischemia and its consequences including heart failure, which itself has emerged as
the leading cause of morbidity and mortality in developed countries are accompanied by …
the leading cause of morbidity and mortality in developed countries are accompanied by …
Glucose metabolism and cardiac hypertrophy
The most notable change in the metabolic profile of hypertrophied hearts is an increased
reliance on glucose with an overall reduced oxidative metabolism, ie a reappearance of the …
reliance on glucose with an overall reduced oxidative metabolism, ie a reappearance of the …
Energy metabolism in the normal and failing heart: potential for therapeutic interventions
WC Stanley, MP Chandler - Heart failure reviews, 2002 - Springer
The chronically failing heart has been shown to be metabolically abnormal, in both animal
models and in patients. Little data are available on the rate of myocardial glucose, lactate …
models and in patients. Little data are available on the rate of myocardial glucose, lactate …
Growth differentiation factor 15, ST2, high‐sensitivity troponin T, and N‐terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection …
R Santhanakrishnan, JPC Chong, TP Ng… - European journal of …, 2012 - Wiley Online Library
Aims Growth differentiation factor 15 (GDF15), ST2, high‐sensitivity troponin T (hsTnT), and
N‐terminal pro brain natriuretic peptide (NT‐proBNP) are biomarkers of distinct mechanisms …
N‐terminal pro brain natriuretic peptide (NT‐proBNP) are biomarkers of distinct mechanisms …
Cardiolipin and apoptosis
JB McMillin, W Dowhan - Biochimica et Biophysica Acta (BBA)-Molecular …, 2002 - Elsevier
Cardiolipin (CL) is recognized to be an essential phospholipid in eukaryotic energy
metabolism so that physiological and pathological perturbations in its synthetic and …
metabolism so that physiological and pathological perturbations in its synthetic and …
Metabolic manipulation in ischaemic heart disease, a novel approach to treatment
L Lee, J Horowitz, M Frenneaux - European heart journal, 2004 - academic.oup.com
Antianginal drugs that exert their anti-ischaemic effects primarily by altering myocardial
metabolism have recently attracted attention. They have the potential to relieve symptoms in …
metabolism have recently attracted attention. They have the potential to relieve symptoms in …
First clinical trial with etomoxir in patients with chronic congestive heart failure
S SCHMIDT-SCHWEDA, C HOLUBARSCH - Clinical science, 2000 - portlandpress.com
In the failing human myocardium, both impaired calcium homoeostasis and alterations in the
levels of contractile proteins have been observed, which may be responsible for reduced …
levels of contractile proteins have been observed, which may be responsible for reduced …